Skip to main content
. 2021 Oct 28;11:760389. doi: 10.3389/fonc.2021.760389

Table 1.

Clinical characteristics of the patients according to LCR before PSM.

Characteristics All patientsN = 201 LCR p-Value
Low LCR High LCR
N = 62 N = 139
Age, years 0.001
 ≤65 97 (48.3) 19 (30.6) 78 (56.1)
 >65 104 (51.7) 43 (69.4) 61 (43.9)
Sex 0.883
 Male 174 (86.6) 54 (87.1) 120 (86.3)
 Female 27 (13.4) 8 (12.9) 19 (13.7)
BMI, kg/m2 0.002
 ≤24 120 (59.7) 47 (75.8) 73 (52.5)
 >24 81 (40.3) 15 (24.2) 66 (47.5)
CCI 0.222
 ≤2 126 (62.7) 35 (56.5) 91 (65.5)
 >2 75 (37.3) 27 (43.5) 48 (34.5)
T stage 0.352
 T1 79 (39.3) 20 (32.3) 59 (42.4)
 T2 43 (21.4) 12 (19.4) 31 (22.3)
 T3 41 (20.4) 15 (24.2) 26 (18.7)
 T4 38 (18.9) 15 (24.2) 23 (16.5)
N stage 0.090
 N0 166 (82.6) 47 (75.8) 119 (85.6)
 N+ 35 (17.4) 15 (24.2) 20 (14.4)
M stage 0.366
 M0 192 (95.5) 58 (93.5) 134 (96.4)
 M1 9 (4.5) 4 (6.5) 5 (3.6)
Grade 0.273
 Low grade 12 (6.0) 2 (3.2) 10 (7.2)
 High grade 189 (94.0) 60 (96.8) 129 (92.8)

PSM, propensity score matching; LCR, lymphocyte–C-reactive protein ratio; CCI, comprehensive complication index; BMI, body mass index.